Plasma-based Colorectal Cancer Screening Research & Development
Completed
Conditions studied: Colo-rectal Cancer
In brief
The objective of this Clinical Sample Collection Study is to develop a biobank of appropriately collected plasma samples from colorectal cancer patients (i.e. AJCC/UICC stages 0, I, II, III) prior to therapeutic intervention, and from people reporting for colorectal cancer screening by colonoscopy, prior to bowel preparation.
Key facts
- Study ID
- NCT04027790
- Run by
- Epigenomics, Inc
- People needed
- 354
- Starts
- 2019-05-03
- Expected to finish
- 2020-03-31
- Last updated by the study team
- 2021-02-02
Who can join
Age: 45 and older, up to 84. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of South Florida — Tampa, Florida, United States
- Springfield Clinic — Springfield, Illinois, United States
- Ochsner Clinic Foundation — New Orleans, Louisiana, United States
- Washington University — St Louis, Missouri, United States
- University of Pennsylvania Perelman Center for Advanced Medicine — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.